Balancing adoption and affordability of medical devices in Europe
Author
Abstract
Suggested Citation
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
References listed on IDEAS
- Cutler, David M., 2007.
"The lifetime costs and benefits of medical technology,"
Journal of Health Economics, Elsevier, vol. 26(6), pages 1081-1100, December.
- David M. Cutler, 2007. "The Lifetime Costs and Benefits of Medical Technology," NBER Working Papers 13478, National Bureau of Economic Research, Inc.
- Jonas Schreyögg & Tom Stargardt & Oliver Tiemann & Reinhard Busse, 2006. "Methods to determine reimbursement rates for diagnosis related groups (DRG): A comparison of nine European countries," Health Care Management Science, Springer, vol. 9(3), pages 215-223, August.
- Andreas Werblow & Stefan Felder & Peter Zweifel, 2007. "Population ageing and health care expenditure: a school of ‘red herrings’?," Health Economics, John Wiley & Sons, Ltd., vol. 16(10), pages 1109-1126, October.
- Aleksandra Torbica & Giovanni Fattore, 2005. "The “Essential Levels of Care” in Italy: when being explicit serves the devolution of powers," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 6(1), pages 46-52, November.
- Di Matteo, Livio, 2005. "The macro determinants of health expenditure in the United States and Canada: assessing the impact of income, age distribution and time," Health Policy, Elsevier, vol. 71(1), pages 23-42, January.
- Cutler, David, 2007. "The Lifetime Costs and Benefits of Medical Technology," Scholarly Articles 2643640, Harvard University Department of Economics.
- Simoens, Steven & De Coster, Sandra & Moldenaers, Ingrid & Guillaume, Paul & Depoorter, Antony & Van den Steen, Dirk & Van de Sande, Stefaan & Debruyne, Hans & Ramaekers, Dirk & Lona, Murielle, 2008. "Reforming the Belgian market for orthotic braces: What can we learn from the international experience?," Health Policy, Elsevier, vol. 86(2-3), pages 195-203, May.
- Office of Health Economics, 2007. "The Economics of Health Care," For School 001490, Office of Health Economics.
- Rosanna Tarricone & Monia Marchetti & Mark Lamotte & Lieven Annemans & Peter Jong, 2004. "What reimbursement for coronary revascularization with drug-eluting stents?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 5(4), pages 309-316, November.
- Cookson, Richard & Hutton, John, 2003. "Regulating the economic evaluation of pharmaceuticals and medical devices: a European perspective," Health Policy, Elsevier, vol. 63(2), pages 167-178, February.
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Henschke, Cornelia, 2012. "Provision and financing of assistive technology devices in Germany: A bureaucratic odyssey? The case of amyotrophic lateral sclerosis and Duchenne muscular dystrophy," Health Policy, Elsevier, vol. 105(2), pages 176-184.
- Maximilian H. M. Hatz & Jonas Schreyögg & Aleksandra Torbica & Giuseppe Boriani & Carl R. B. Blankart, 2017. "Adoption Decisions for Medical Devices in the Field of Cardiology: Results from a European Survey," Health Economics, John Wiley & Sons, Ltd., vol. 26(S1), pages 124-144, February.
- Levaggi, Rosella & Moretto, Michele & Pertile, Paolo, 2014. "Two-part payments for the reimbursement of investments in health technologies," Health Policy, Elsevier, vol. 115(2), pages 230-236.
- Zippel, Claus & Bohnet-Joschko, Sabine, 2017. "Post market surveillance in the german medical device sector – current state and future perspectives," Health Policy, Elsevier, vol. 121(8), pages 880-886.
- Joyce Craig & Louise Carr & John Hutton & Julie Glanville & Cynthia Iglesias & Andrew Sims, 2015. "A Review of the Economic Tools for Assessing New Medical Devices," Applied Health Economics and Health Policy, Springer, vol. 13(1), pages 15-27, February.
- Fischer, Katharina E. & Rogowski, Wolf H. & Leidl, Reiner & Stollenwerk, Björn, 2013. "Transparency vs. closed-door policy: Do process characteristics have an impact on the outcomes of coverage decisions? A statistical analysis," Health Policy, Elsevier, vol. 112(3), pages 187-196.
- Rachet-Jacquet, Laurie & Toulemon, Léa & Rochaix, Lise, 2021.
"Hospital payment schemes and high-priced drugs: Evidence from the French Add-on List,"
Health Policy, Elsevier, vol. 125(7), pages 923-929.
- Laurie Rachet-Jacquet & Léa Toulemon & Lise Rochaix, 2021. "Hospital payment schemes and high-priced drugs: Evidence from the French Add-on List," Post-Print halshs-03238834, HAL.
- Laurie Rachet-Jacquet & Léa Toulemon & Lise Rochaix, 2021. "Hospital payment schemes and high-priced drugs: Evidence from the French Add-on List," Institut des Politiques Publiques halshs-03238834, HAL.
- Laurie Rachet-Jacquet & Léa Toulemon & Lise Rochaix, 2021. "Hospital payment schemes and high-priced drugs: Evidence from the French Add-on List," PSE-Ecole d'économie de Paris (Postprint) halshs-03238834, HAL.
- Kastanioti, Catherine & Kontodimopoulos, Nick & Stasinopoulos, Dionysis & Kapetaneas, Nikolaos & Polyzos, Nikolaos, 2013. "Public procurement of health technologies in Greece in an era of economic crisis," Health Policy, Elsevier, vol. 109(1), pages 7-13.
- Gallego, Gisselle & Casey, Robert & Norman, Richard & Goodall, Stephen, 2011. "Introduction and uptake of new medical technologies in the Australian health care system: A qualitative study," Health Policy, Elsevier, vol. 102(2), pages 152-158.
- Rosella Levaggi & Michele Moretto & Paolo Pertile, 2012. "DRGs: the link between investment in technologies and appropriateness," Working Papers 31/2012, University of Verona, Department of Economics.
- Rosanna Tarricone & Aleksandra Torbica & Michael Drummond, 2017. "Challenges in the Assessment of Medical Devices: The MedtecHTA Project," Health Economics, John Wiley & Sons, Ltd., vol. 26(S1), pages 5-12, February.
- Giuditta Callea & Aleksandra Torbica & Rosanna Tarricone, 2014. "Impatto del sistema di finanziamento a DRG sull?innovazione tecnologica in sanit?. Il caso italiano," MECOSAN, FrancoAngeli Editore, vol. 2014(89), pages 31-48.
- Tödtling, Franz & Sinozic, Tanja & Auer, Alexander, 2016.
"Knowledge bases, multi-scale interaction and transformation of the Vienna medical cluster,"
SRE-Discussion Papers
2016/03, WU Vienna University of Economics and Business.
- Franz Tödtling & Tanja Sinozic & Alexander Auer, 2016. "Knowledge bases, multi-scale interaction and transformation of the Vienna medical cluster," SRE-Disc sre-disc-2016_03, Institute for Multilevel Governance and Development, Department of Socioeconomics, Vienna University of Economics and Business.
- Amitabh Chandra & Jonathan S. Skinner, 2011. "Technology Growth and Expenditure Growth in Health Care," NBER Working Papers 16953, National Bureau of Economic Research, Inc.
- Beck, ACC & Retèl, VP & Bhairosing, PA & van den Brekel, MWM & van Harten, WH, 2019. "Barriers and facilitators of patient access to medical devices in Europe: A systematic literature review," Health Policy, Elsevier, vol. 123(12), pages 1185-1198.
- Peckham, Allie & Miller, Fiona A. & Marchildon, Gregory P., 2021. "Comparison of outpatient coverage in Canada: Assistive and medical devices," Health Policy, Elsevier, vol. 125(12), pages 1536-1542.
- Deo, Sarang & Tyagi, Hanu & Chatterjee, Chirantan & Molakapuri, Himasagar, 2020. "Did India's price control policy for coronary stents create unintended consequences?," Social Science & Medicine, Elsevier, vol. 246(C).
- Sorenson, Corinna & Kanavos, Panos, 2011. "Medical technology procurement in Europe: A cross-country comparison of current practice and policy," Health Policy, Elsevier, vol. 100(1), pages 43-50, April.
- Martelli, Nicolas & van den Brink, Hélène, 2014. "Special funding schemes for innovative medical devices in French hospitals: The pros and cons of two different approaches," Health Policy, Elsevier, vol. 117(1), pages 1-5.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Fabio Pammolli & Francesco Porcelli & Francesco Vidoli & Monica Auteri & Guido Borà, 2017. "La spesa sanitaria delle Regioni in Italia - Saniregio2017," Working Papers CERM 01-2017, Competitività, Regole, Mercati (CERM).
- Carsten Colombier, 2018.
"Population ageing in healthcare – a minor issue? Evidence from Switzerland,"
Applied Economics, Taylor & Francis Journals, vol. 50(15), pages 1746-1760, March.
- Colombier, Carsten, 2016. "Population aging in healthcare - a minor issue? Evidence from Switzerland," FiFo Discussion Papers - Finanzwissenschaftliche Diskussionsbeiträge 16-3, University of Cologne, FiFo Institute for Public Economics.
- Peter Willemé & Michel Dumont, 2016.
"Machines that go ‘ping’: Medical Technology and Health Expenditures in OECD Countries,"
Health Economics, John Wiley & Sons, Ltd., vol. 25(3), pages 387-388, March.
- Peter Willemé & Michel Dumont, 2015. "Machines that Go ‘Ping’: Medical Technology and Health Expenditures in OECD Countries," Health Economics, John Wiley & Sons, Ltd., vol. 24(8), pages 1027-1041, August.
- Maciej Lis, 2016. "Age or time-to-death – what drives health care expenditures? Panel data evidence from the OECD countries," IBS Working Papers 04/2016, Instytut Badan Strukturalnych.
- Michael Bäumler & Tom Stargardt & Jonas Schreyögg & Reinhard Busse, 2012. "Cost Effectiveness of Drug-Eluting Stents in Acute Myocardial Infarction Patients in Germany," Applied Health Economics and Health Policy, Springer, vol. 10(4), pages 235-248, July.
- de Meijer, Claudine & O’Donnell, Owen & Koopmanschap, Marc & van Doorslaer, Eddy, 2013.
"Health expenditure growth: Looking beyond the average through decomposition of the full distribution,"
Journal of Health Economics, Elsevier, vol. 32(1), pages 88-105.
- Claudine de Meijer & Marc Koopmanschap & Owen O'Donnell & Eddy van Doorslaer, 2012. "Health Expenditure Growth: Looking beyond the Average through Decomposition of the Full Distribution," Tinbergen Institute Discussion Papers 12-051/3, Tinbergen Institute.
- Giuditta Callea & Aleksandra Torbica & Rosanna Tarricone, 2014. "Impatto del sistema di finanziamento a DRG sull?innovazione tecnologica in sanit?. Il caso italiano," MECOSAN, FrancoAngeli Editore, vol. 2014(89), pages 31-48.
- Michel Dumont & Peter Willemé, 2013. "Working Paper 02-13 - Machines that go ‘ping’: medical technology and health expenditures in OECD countries," Working Papers 1302, Federal Planning Bureau, Belgium.
- Trottmann, Maria & Zweifel, Peter & Beck, Konstantin, 2012. "Supply-side and demand-side cost sharing in deregulated social health insurance: Which is more effective?," Journal of Health Economics, Elsevier, vol. 31(1), pages 231-242.
- Margaret Oppenheimer & Helen LaVan & William Martin, 2015. "A Framework for Understanding Ethical and Efficiency Issues in Pharmaceutical Intellectual Property Litigation," Journal of Business Ethics, Springer, vol. 132(3), pages 505-524, December.
- Colombier, Carsten & Weber, Werner, 2009.
"Projecting health-care expenditure for Switzerland: further evidence against the 'red-herring' hypothesis,"
MPRA Paper
26747, University Library of Munich, Germany, revised Nov 2009.
- Colombier, Carsten & Weber, Werner, 2009. "Projecting health-care expenditure for Switzerland: further evidence against the 'red-herring' hypothesis," MPRA Paper 26712, University Library of Munich, Germany, revised Jun 2010.
- Moreno Gigi & van Eijndhoven Emma & Benner Jennifer & Sullivan Jeffrey, 2017. "The Long-Term Impact of Price Controls in Medicare Part D," Forum for Health Economics & Policy, De Gruyter, vol. 20(2), pages 1-56, December.
- Kuhn, Michael & Frankovic, Ivan & Wrzaczek, Stefan, 2017.
"Medical Progress, Demand for Health Care, and Economic Performance,"
VfS Annual Conference 2017 (Vienna): Alternative Structures for Money and Banking
168249, Verein für Socialpolitik / German Economic Association.
- Frankovic, Ivan & Kuhn, Michael & Wrzaczek, Stefan, 2017. "Medical progress, demand for health care, and economic performance," ECON WPS - Working Papers in Economic Theory and Policy 08/2017, TU Wien, Institute of Statistics and Mathematical Methods in Economics, Economics Research Unit.
- Li, Jing, 2014. "The influence of state policy and proximity to medical services on health outcomes," Journal of Urban Economics, Elsevier, vol. 80(C), pages 97-109.
- Błażej Łyszczarz, 2018. "Determinanty wydatków na zdrowie w gospodarstwach domowych w Polsce," Gospodarka Narodowa. The Polish Journal of Economics, Warsaw School of Economics, issue 1, pages 137-157.
- Dokow, Elad & Luque, Jaime, 2019. "Provision of local public goods in mixed income communities," Journal of Housing Economics, Elsevier, vol. 45(C), pages 1-1.
- Friedrich Breyer & Normann Lorenz & Thomas Niebel, 2015.
"Health care expenditures and longevity: is there a Eubie Blake effect?,"
The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 16(1), pages 95-112, January.
- Friedrich Breyer & Normann Lorenz & Thomas Niebel, 2012. "Health Care Expenditures and Longevity: Is There a Eubie Blake Effect?," Discussion Papers of DIW Berlin 1226, DIW Berlin, German Institute for Economic Research.
- Friedrich Breyer & Normann Lorenz & Thomas Niebel, 2012. "Health Care Expenditures and Longevity: Is there a Eubie Blake Effect?," Research Papers in Economics 2012-01, University of Trier, Department of Economics.
- Alice Sanwald & Thomas Schober, 2014.
"Follow your Heart: Survival chances and costs after Heart Attacks – An instrumental Variable Approach,"
CDL Aging, Health, Labor working papers
1503, The Christian Doppler (CD) Laboratory Aging, Health, and the Labor Market, Johannes Kepler University Linz, Austria.
- Alice Sanwald & Thomas Schober, 2014. "Follow your Heart: Survival Chances and Costs after Heart Attacks - An Instrumental Variable Approach," Working Papers 2014-26, Faculty of Economics and Statistics, Universität Innsbruck.
- Alice Sanwald & Thomas Schober, 2014. "Follow your Heart: Survival Chances and Costs after Heart Attacks - An Instrumental Variable Approach," Economics working papers 2014-12, Department of Economics, Johannes Kepler University Linz, Austria.
- Alice Sanwald & Thomas Schober, 2014. "Follow your Heart: Survival Chances and Costs after Heart Attacks - An Instrumental Variable Approach," NRN working papers 2014-13, The Austrian Center for Labor Economics and the Analysis of the Welfare State, Johannes Kepler University Linz, Austria.
- Vincenzo Atella & Valentina Conti, 2013. "The effect of age and time to death on health care expenditures: the Italian experience," CEIS Research Paper 267, Tor Vergata University, CEIS, revised 12 Nov 2013.
- N. Meltem Daysal & Mircea Trandafir & Reyn van Ewijk, 2015.
"Saving Lives at Birth: The Impact of Home Births on Infant Outcomes,"
American Economic Journal: Applied Economics, American Economic Association, vol. 7(3), pages 28-50, July.
- Meltem Daysal, N. & Trandafir, M. & van Ewijk, R., 2012. "Saving Lives at Birth : The Impact of Home Births on Infant Outcomes," Other publications TiSEM 4d2a6ef1-4496-4cd4-95d7-b, Tilburg University, School of Economics and Management.
- Daysal, N. Meltem & Trandafir, Mircea & van Ewijk, Reyn, 2012. "Saving Lives at Birth: The Impact of Home Births on Infant Outcomes," IZA Discussion Papers 6879, Institute of Labor Economics (IZA).
- N. Meltem Daysal & Mircea Trandafir & Reyn van Ewijk, 2012. "Saving Lives at Birth: The Impact of Home Births on Infant Outcomes," Cahiers de recherche 12-11, Departement d'économique de l'École de gestion à l'Université de Sherbrooke.
- N. Meltem Daysal & Mircea Trandafir & Reyn van Ewijk, 2014. "Saving Lives at Birth: The Impact of Home Births on Infant Outcomes," Working Papers 1409, Gutenberg School of Management and Economics, Johannes Gutenberg-Universität Mainz, revised 18 Sep 2014.
- Meltem Daysal, N. & Trandafir, M. & van Ewijk, R., 2012. "Saving Lives at Birth : The Impact of Home Births on Infant Outcomes," Discussion Paper 2012-077, Tilburg University, Center for Economic Research.
More about this item
Keywords
Medical devices Resource allocation Financing Regulation Europe;Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:hepoli:v:92:y:2009:i:2-3:p:218-224. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu or the person in charge (email available below). General contact details of provider: http://www.elsevier.com/locate/healthpol .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.